Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Peter Hartung

Showing results (31-40 of 601) with videos related to

Pageof 61
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 10, 2018
ECTRIMS/ACTRIMS 2017: Closing in on neurorepair in progressive multiple sclerosisDavid Kremer, Patrick Küry, Hans-Peter Hartung
Plos One|September 7, 2012
Interferon gamma and sonic hedgehog signaling are required to dysregulate murine neural stem/precursor cellsJanine Walter, Hans-Peter Hartung, Marcel Dihné
Stroke|July 9, 2011
Restoring neuronal function after stroke by cell replacement: anatomic and functional considerationsMarcel Dihné, Hans-Peter Hartung, Rüdiger J Seitz
Pharmacology & Therapeutics|August 13, 2005
Therapeutic role of mitoxantrone in multiple sclerosisOliver Neuhaus, Bernd C Kieseier, Hans-Peter Hartung
Current Opinion in Neurology|May 14, 2005
Multiple sclerosis--novel insights and new therapeutic strategiesBernd C Kieseier, Bernhard Hemmer, Hans-Peter Hartung
Journal of Neurology|November 19, 2004
What do we know about the mechanism of action of disease-modifying treatments in MS?Hans-Peter Hartung, Amit Bar-Or, Yannis Zoukos
Neurology|May 30, 2018
150th anniversary of clinical description of multiple sclerosis: Leopold Ordenstein's legacyHelmar C Lehmann, Alastair Compston, Hans-Peter Hartung
Trends in Pharmacological Sciences|May 25, 2015
IVIg for relapsing-remitting multiple sclerosis: promises and uncertaintiesJagadeesh Bayry, Hans-Peter Hartung, Srini V Kaveri
Expert Review of Neurotherapeutics|April 28, 2005
Mitoxantrone (Novantrone) in multiple sclerosis: new insightsOliver Neuhaus, Bernd C Kieseier, Hans-Peter Hartung
Muscle & Nerve|April 4, 2006
Mycophenolate mofetil and tacrolimus: new therapeutic options in neuroimmunological diseasesChristiane Schneider-Gold, Hans-Peter Hartung, Ralf Gold
Pageof 61

Showing results (31-40 of 601) with videos related to

Sort By:
Pageof 61
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 10, 2018
ECTRIMS/ACTRIMS 2017: Closing in on neurorepair in progressive multiple sclerosisDavid Kremer, Patrick Küry, Hans-Peter Hartung
Plos One|September 7, 2012
Interferon gamma and sonic hedgehog signaling are required to dysregulate murine neural stem/precursor cellsJanine Walter, Hans-Peter Hartung, Marcel Dihné
Stroke|July 9, 2011
Restoring neuronal function after stroke by cell replacement: anatomic and functional considerationsMarcel Dihné, Hans-Peter Hartung, Rüdiger J Seitz
Pharmacology & Therapeutics|August 13, 2005
Therapeutic role of mitoxantrone in multiple sclerosisOliver Neuhaus, Bernd C Kieseier, Hans-Peter Hartung
Current Opinion in Neurology|May 14, 2005
Multiple sclerosis--novel insights and new therapeutic strategiesBernd C Kieseier, Bernhard Hemmer, Hans-Peter Hartung
Journal of Neurology|November 19, 2004
What do we know about the mechanism of action of disease-modifying treatments in MS?Hans-Peter Hartung, Amit Bar-Or, Yannis Zoukos
Neurology|May 30, 2018
150th anniversary of clinical description of multiple sclerosis: Leopold Ordenstein's legacyHelmar C Lehmann, Alastair Compston, Hans-Peter Hartung
Trends in Pharmacological Sciences|May 25, 2015
IVIg for relapsing-remitting multiple sclerosis: promises and uncertaintiesJagadeesh Bayry, Hans-Peter Hartung, Srini V Kaveri
Expert Review of Neurotherapeutics|April 28, 2005
Mitoxantrone (Novantrone) in multiple sclerosis: new insightsOliver Neuhaus, Bernd C Kieseier, Hans-Peter Hartung
Muscle & Nerve|April 4, 2006
Mycophenolate mofetil and tacrolimus: new therapeutic options in neuroimmunological diseasesChristiane Schneider-Gold, Hans-Peter Hartung, Ralf Gold
Pageof 61